ScholarIQanswers from OpenAlex
Chan Zuckerberg Biohub San Francisco
InstitutionResearch output, impact & collaborations
Chan Zuckerberg Biohub San Francisco is a institution indexed in ScholarIQ from OpenAlex.
What is known about Chan Zuckerberg Biohub San Francisco?
ScholarIQrecord summary
Chan Zuckerberg Biohub San Francisco is a research organisation in San Francisco, United States. OpenAlex records 1,072 works and 10,161 citations for it. 5 researchers list it as their most recent affiliation.
How many works does Chan Zuckerberg Biohub San Francisco have?
ScholarIQindexed works
Chan Zuckerberg Biohub San Francisco has 1,072 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Chan Zuckerberg Biohub San Francisco have?
ScholarIQcitation count
Chan Zuckerberg Biohub San Francisco has 10,161 citations in the OpenAlex counts ScholarIQ stores.
How many researchers are at Chan Zuckerberg Biohub San Francisco?
ScholarIQresearcher count
Chan Zuckerberg Biohub San Francisco has 5 researchers in the ScholarIQ index.
What is the average h-index at Chan Zuckerberg Biohub San Francisco?
ScholarIQavg h-index
Chan Zuckerberg Biohub San Francisco has an average h-index of 71.4 in OpenAlex.
What is the ROR of Chan Zuckerberg Biohub San Francisco?
ScholarIQror
The ROR for Chan Zuckerberg Biohub San Francisco is on the source record.
What is the OpenAlex record for Chan Zuckerberg Biohub San Francisco?
ScholarIQopenalex
The OpenAlex for Chan Zuckerberg Biohub San Francisco is on the source record.
Who are the most-cited researchers behind Chan Zuckerberg Biohub San Francisco?
ScholarIQtop researchers by citations
What are the most-cited papers on Chan Zuckerberg Biohub San Francisco?
ScholarIQmost cited works
BAY 43-9006 Exhibits Broad Spectrum Oral Antitumor Activity and Targets the RAF/MEK/ERK Pathway and Receptor Tyrosine Kinases Involved in Tumor Progression and Angiogenesis
Scott M. Wilhelm, Christopher Carter, LiYa Tang, Dean Wilkie, Angela McNabola, Hong Rong, Charles Chen, Xiaomei Zhang, Patrick W. Vincent, Mark McHugh, Yichen Cao, Jaleel Shujath, Susan L. Gawlak, Deepa Eveleigh, Bruce R. Rowley, Li Liu, Lila Adnane, Mark Lynch, Daniel Auclair, I Taylor, Rich Gedrich, Andrei Voznesensky, Bernd Riedl, Leonard Post, Gideon Bollag, Pamela A. Trail
Association of reactive oxygen species levels and radioresistance in cancer stem cells
Maximilian Diehn, Robert W. Cho, Neethan A. Lobo, Tomer Kalisky, Mary J. Dorie, Angela N. Kulp, Dalong Qian, Jessica Lam, Laurie Ailles, Manzhi Wong, Ben‐Zion Joshua, Michael J. Kaplan, Irene Wapnir, Frederick M. Dirbas, George Somlo, Carlos A. Garberoglio, Benjamin Paz, Jeannie Shen, Sean K. Lau, Stephen R. Quake, Janice M. Brown, Irving L. Weissman, Michael F. Clarke
Mutations in prion-like domains in hnRNPA2B1 and hnRNPA1 cause multisystem proteinopathy and ALS
Hong Joo Kim, Nam Chul Kim, Yong‐Dong Wang, Emily A. Scarborough, Jennifer C. Moore, Zamia Diaz, Kyle S. MacLea, Brian D. Freibaum, Songqing Li, Amandine Molliex, Anderson Kanagaraj, Robert Carter, Khrista Boylan, Aleksandra Wojtas, Rosa Rademakers, Jack L. Pinkus, Steven A. Greenberg, John Q. Trojanowski, Bryan J. Traynor, Bradley Smith, Simon Topp, Athina-Soragia Gkazi, Jack W. Miller, Christopher E. Shaw, Michael Kottlors, Janbernd Kirschner, Alan Pestronk, Yun R. Li, Alice F. Ford, Aaron D. Gitler, Michael Benatar, Oliver D. King, Virginia Kimonis, Eric D. Ross, Conrad C. Weihl, James Shorter, J. Paul Taylor
<i>RAS</i> Mutations in Cutaneous Squamous-Cell Carcinomas in Patients Treated with BRAF Inhibitors
Fei Su, Amaya Virós, Carla Milagre, Kerstin Trunzer, Gideon Bollag, Olivia Spleiss, Jorge S. Reis‐Filho, Xiangju Kong, Richard C. Koya, Keith T. Flaherty, Paul B. Chapman, Min Jung Kim, Robert Hayward, Matthew J. Martin, Hong Yang, Qiongqing Wang, Holly Hilton, Julie S. Hang, Johannes Noé, Maryou Lambros, Felipe C. Geyer, Nathalie Dhomen, Ion Niculescu‐Duvaz, Alfonso Zambon, Dan Niculescu‐Duvaz, Natasha Preece, Lídia Robert, Nicholas Otte, Stephen Mok, Damien Kee, Yan Ma, Chao Zhang, Gaston Habets, Elizabeth A. Burton, Bernice H. Wong, Hoa Nguyen, Mark Kockx, Luc Andries, Brian Lestini, K. B. Nolop, Richard J. Lee, Andrew K. Joe, James L. Troy, René González, Thomas E. Hutson, Igor Puzanov, Bartosz Chmielowski, Caroline J. Springer, Grant A. McArthur, Jeffrey A. Sosman, Roger S. Lo, Antoni Ribas, Richard Marais
Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways
Elizabeth T. Cirulli, Brittany N. Lasseigne, Slavé Petrovski, Peter C. Sapp, Patrick A. Dion, Claire S. Leblond, Julien Couthouis, Yifan Lu, Quanli Wang, Brian J. Krueger, Zhong Ren, Jonathan Keebler, Yujun Han, Shawn Levy, Braden Boone, Jack R. Wimbish, Lindsay L. Waite, Angela L. Jones, John P. Carulli, Kelly L. Williams, John F. Staropoli, Winnie Xin, Alessandra Chesi, Alya R. Raphael, Diane McKenna‐Yasek, Janet Cady, J.M.B.V. de Jong, Kevin P. Kenna, Bradley Smith, Simon Topp, Jack W. Miller, Soragia Athina Gkazi, Ammar Al‐Chalabi, Leonard H. van den Berg, Jan H. Veldink, Vincenzo Silani, Nicola Ticozzi, Christopher E. Shaw, Robert H. Baloh, Stanley H. Appel, Ericka Simpson, Clotilde Lagier‐Tourenne, Stefan M. Pulst, Summer Gibson, John Q. Trojanowski, Lauren Elman, Leo McCluskey, Murray Grossman, Neil A. Shneider, Wendy K. Chung, John Ravits, Jonathan D. Glass, Katherine B. Sims, Vivianna M. Van Deerlin, Tom Maniatis, Sebastian Hayes, Alban Ordureau, Sharan Swarup, John E. Landers, Frank Baas, Andrew S. Allen, Richard Bedlack, J. Wade Harper, Aaron D. Gitler, Guy A. Rouleau, Robert H. Brown, Matthew B. Harms, Gregory M. Cooper, Tim Harris, R Myers, David B. Goldstein
How much of the research on Chan Zuckerberg Biohub San Francisco is open access?
ScholarIQopen access share
82%OPEN ACCESS